Occlutech International Ab

This study is tracking the safety and effectiveness of a small device called the Occlutech Atrial Flow Regulator in 150 people with chronic heart failure. The device is implanted to create a small opening between the upper chambers of the heart, which may help reduce pressure and…

This program allows patients to receive Occlutech's atrial flow regulator, a device implanted via catheter to help control blood flow between the upper chambers of the heart. It is available under the FDA's Expanded Access program for those who meet eligibility criteria. The goal…

This study is testing a device called the Occlutech mVSD Occluder to close a type of hole in the heart (muscular ventricular septal defect) without open surgery. The device is inserted through a blood vessel in the leg and guided to the heart. Researchers will follow 50 patients …

This study follows 255 patients of any age (weighing over 3 kg) who receive a device called the Occlutech PDA Occluder to close a common heart defect called patent ductus arteriosus (PDA). The device is inserted through a blood vessel, avoiding open-heart surgery. Researchers wil…

This study is a registry that tracks the safety and performance of four accessory devices used during heart implant procedures. Researchers will collect data from about 685 participants across multiple countries by having doctors fill out surveys after each procedure. The goal is…